Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by BAIK BRIAN SEUNG WON(백승원), Chairman & CEO. Director active across 2 companies, notably 케이엠제약. Aggregated, 10 reports have been logged. Activity tracked since 9 March 2026. The latest transaction was disclosed on 15 April 2026 (Purchase). Regulator: DART (FSS). All data is free.
BAIK BRIAN SEUNG WON is the Chairman & CEO of KM Pharmaceutical. He is responsible for the strategic direction of the company and the management of daily operations. With his experience, BAIK BRIAN SEUNG WON plays a key role in strategic decision-making and defining the company's long-term vision.